CSI Market
Sign In | Register

Cosciens Biopharma Inc (CSCI) Annual Balance Sheets

Annual · GAAP · USD millions
Access CSCI quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Cosciens Biopharma Inc's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents7.31
Current Tax Assets Current0.00
Cash & Short-term Investments7.00
Accounts receivable1.08
Trade & Other Current Receivables (IFRS combined total)1.26
Inventories1.31
Other Current Assets2.89
Total Current Assets11.50
Equipment/Property/Plant Net9.81
Goodwill net0.00
Intangible Assets0.00
Long-term investments0.13
Tax Assets, Noncurrent1.12
Other Assets, Noncurrent0.13
Trade And Other Current Receivables1.26
Inventories Total-
Current Prepayments And Other Current Assets1.59
Intangible Assets Other Than Goodwill-
Total Assets21.43
Liabilities
Current Tax Liabilities0.12
Other Liabilities, Current3.49
Deferred Liability and Revenue0.00
Total Current Liabilities3.61
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent1.12
Noncurrent Provisions0.27
OtherLongtermProvisions13.98
Current Portion Of Deferred Revenues-
Current Lease Liabilities0.22
Total Liabilities17.59
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity0.00
Total Stockholder's Equity0.00
Liabilities & Stockholder's Equity21.43
4 historic quarters locked

Sign in to unlock the full Cosciens Biopharma Inc balance sheet history.

Sign In Create Free Account

About Cosciens Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 25, 2026
  • Source: form20-f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-012703

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.